UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Rituximab-related cryptogenic organizing pneumonia and late onset neutropenia in a patient with non-Hodgkin lymphoma: report of two rare complications and review of the literature

Journal of B.U. ON., 2012-07, Vol.17 (3), p.602-603

2012

Volltextzugriff (PDF)

Severe vascular toxicity associated with cisplatin‐based chemotherapy

Cancer, 1993-07, Vol.72 (2), p.587-593

1993

Volltextzugriff (PDF)

Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium : an immunohistochemical study of 151 cases

Virchows Archiv : an international journal of pathology, 2005-07, Vol.447 (1), p.24-30

2005

Volltextzugriff (PDF)

The outcome of patients with triple negative breast cancer: Evidence for a favorable ethnic subgroup? The Turkish Oncology Group experience

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e22158-e22158

2009

Volltextzugriff (PDF)

Value of combined 67Ga and 99Tcm-human immunoglobulin G whole-body scanning in malignant lymphoma

Nuclear medicine communications, 2001-03, Vol.22 (3), p.325-329

2001

Volltextzugriff (PDF)

Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte‐macrophage–colony stimulating factor in patients with soft tissue or bone sarcoma

Cancer, 2000-05, Vol.88 (9), p.2033-2036

2000

Volltextzugriff (PDF)

A randomized trial of four cycles of adjuvant AC (adriamycin + cyclophosphamide) ± two cycles of EP (etoposide + cisplatin) in node positive patients with breast cancer

Annals of oncology, 2001-07, Vol.12 (7), p.1011-1013

2001

Volltextzugriff (PDF)

Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2001-08, Vol.33 (2), p.109-114

2001

Volltextzugriff (PDF)

Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer

Journal of surgical oncology, 1997-04, Vol.64 (4), p.318-323

1997

Volltextzugriff (PDF)

Concurrent occurrence of three neoplasms including non-Hodgkin's lymphoma, renal cell carcinoma and leiomyoma in the same kidney

Cancer Immunology, Immunotherapy, 1999-07, Vol.16 (2), p.134-138

1999

Volltextzugriff (PDF)

Primary gastrointestinal lymphomas in Turkey: A retrospective analysis of clinical features and results of treatment

Journal of surgical oncology, 1992-12, Vol.51 (4), p.270-273

1992

Volltextzugriff (PDF)

Addition of 2 cycles of EP (Etoposide + Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin + cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.554-554

2004

Volltextzugriff (PDF)

Addition of 2 cycles of EP (Etoposide + Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin + cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.554-554

2004

Volltextzugriff (PDF)

DIURNAL VARIATIONS OF SERUM GM-CSF LEVELS

Cytokine (Philadelphia, Pa.), 2000-07, Vol.12 (7), p.1151-1155

2000

Volltextzugriff (PDF)

Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer

Journal of surgical oncology, 1992-08, Vol.50 (4), p.251-253

1992

Volltextzugriff (PDF)

Mesna/Ifosfamide, Mitoxantrone, Etoposide, Bleomycin, Vincristine, Prednisone (Mine-Bop) Combination Chemotherapy In The Treatment Of Refractory And Relapsed Non-Hodgkin'S Lymphoma

Acta oncologica, 1995, Vol.34 (7), p.937-940

1995

Volltextzugriff (PDF)

Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma

Medical oncology (Northwood, London, England), 2000-05, Vol.17 (2), p.123-126

2000

Volltextzugriff (PDF)

Diagnostic value of ferritin in the differential diagnosis of malignant effusions

Cancer biochemistry biophysics, 1998-10, Vol.16 (3), p.243

1998

Volltextzugriff (PDF)

Clinicopathologic features and prognostic factors of primary extranodal Non-Hodgkin's lymphomas in Turkey

American journal of clinical oncology, 1999-12, Vol.22 (6), p.587-592

1999

Volltextzugriff (PDF)

The Effects of Chronomodulated Therapy with 5-Fluorouracil (5-Fu) and Folinic Acid (Fa) on the Toxicity and Quality of Life in Patients with Advanced Gastric Cancer

Biological rhythm research, 2004-10, Vol.35 (4-5), p.259-268

2004

Volltextzugriff (PDF)

Adjuvant chemotherapy and scar irradiation in breast cancer

Journal of surgical oncology, 1990-08, Vol.44 (4), p.252-255

1990

Volltextzugriff (PDF)

Phase II Study of Cisplatin and Dacarbazine for Metastatic Colorectal Carcinoma Resistant to 5-Fluorouracil

Oncology, 1999-01, Vol.56 (4), p.297-300

1999

Volltextzugriff (PDF)

Prognostic factors in patients with recurrent breast cancer following mastectomy

European journal of cancer (1990), 1998-09, Vol.34, p.S109-S109

1998

Volltextzugriff (PDF)

Two dose levels of ifosfamide in malignant mesothelioma

Lung cancer (Amsterdam, Netherlands), 1996-09, Vol.15 (2), p.207-213

1996

Volltextzugriff (PDF)

Results of the cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) +/- bleomycin treatment and evaluation of prognostic factors in aggressive lymphomas in Turkey

Oncology, 1997-09, Vol.54 (5), p.376

1997

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(54)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(30)
Male
(26)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Female
(23)
Middle Aged
(23)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Adult
(21)
Oncology
(17)
Aged
(15)
Chemotherapy
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Pharmacology. Drug Treatments
(11)
Antineoplastic Agents
(9)
Adolescent
(8)
Hematologic And Hematopoietic Diseases
(7)
Survival Analysis
(7)
Cisplatin - Administration & Dosage
(6)
Disease-Free Survival
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rituximab-related cryptogenic organizing pneumonia and late onset neutropenia in a patient with non-Hodgkin lymphoma: report of two rare complications and review of the literature

Severe vascular toxicity associated with cisplatin‐based chemotherapy

Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium : an immunohistochemical study of 151 cases

The outcome of patients with triple negative breast cancer: Evidence for a favorable ethnic subgroup? The Turkish Oncology Group experience

Value of combined 67Ga and 99Tcm-human immunoglobulin G whole-body scanning in malignant lymphoma

Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte‐macrophage–colony stimulating factor in patients with soft tissue or bone sarcoma

A randomized trial of four cycles of adjuvant AC (adriamycin + cyclophosphamide) ± two cycles of EP (etoposide + cisplatin) in node positive patients with breast cancer

Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma

Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer

Concurrent occurrence of three neoplasms including non-Hodgkin's lymphoma, renal cell carcinoma and leiomyoma in the same kidney

Primary gastrointestinal lymphomas in Turkey: A retrospective analysis of clinical features and results of treatment

Addition of 2 cycles of EP (Etoposide + Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin + cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years

Addition of 2 cycles of EP (Etoposide + Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin + cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years

DIURNAL VARIATIONS OF SERUM GM-CSF LEVELS

Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer

Mesna/Ifosfamide, Mitoxantrone, Etoposide, Bleomycin, Vincristine, Prednisone (Mine-Bop) Combination Chemotherapy In The Treatment Of Refractory And Relapsed Non-Hodgkin'S Lymphoma

Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma

Diagnostic value of ferritin in the differential diagnosis of malignant effusions

Clinicopathologic features and prognostic factors of primary extranodal Non-Hodgkin's lymphomas in Turkey

The Effects of Chronomodulated Therapy with 5-Fluorouracil (5-Fu) and Folinic Acid (Fa) on the Toxicity and Quality of Life in Patients with Advanced Gastric Cancer

Adjuvant chemotherapy and scar irradiation in breast cancer

Phase II Study of Cisplatin and Dacarbazine for Metastatic Colorectal Carcinoma Resistant to 5-Fluorouracil

Prognostic factors in patients with recurrent breast cancer following mastectomy

Two dose levels of ifosfamide in malignant mesothelioma

Results of the cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) +/- bleomycin treatment and evaluation of prognostic factors in aggressive lymphomas in Turkey

Suchergebnisse filtern